13 ms·
As someone who has been on the corporate side of this type of debate, I can assure you that Gilead has several magnitudes of more information about both of thes
by refurb 7y ago
As someone who has been on the corporate side of this type of debate, I can assure you that Gilead has several magnitudes of more information about both of these molecules than the author has.
And as others have mentioned, the only data for the alternative molecule is animal data versus remdesivir which already has phase 3 data. Sure, the other drug might be better, but it might not work at all.
- maxerickson 7y agoNone of that really addresses the public health policy question of what to do about drugs/compounds that are identified as strong candidate treatments.
- refurb 7y agoI don’t think this alternative is a “strong candidate”. And at any rate, if Gilead choses not to develop it, then someone else can try to license it if they want to gamble on it being a good product.
- fao_ 7y agoSure, and that can include unpublished negative data. Ben Goldacre (a Senior Clinical Research Fellow at the Centre for Evidence Based Medicine in the Department of Primary Care in the University of Oxford{0}), wrote in his book Bad Pharma, about an instance where a specific subset of SSRIs were given to eight(?) year olds for clinical depression. What the GPs prescribing them didn't know, however, was that the suicide rate for those children would go up after prescription. The pharmaceutical company knew about this. It was a negative result, and was unpublished. This is just a single example I've pulled from the book, and the book covers only a smidgen of the hundreds of thousands of cases of incompetence and malice perpetrated by pharmaceutical companies over the last 20 years. You can find more information about this by him here ( https://www.theguardian.com/commentisfree/2008/jan/26/badscience https://www.theguardian.com/commentisfree/2008/jan/26/badsci... ), here ( https://blog.ted.com/5-prescription-drugs-doctors-had-no-idea-could-hurt-their-patients/ https://blog.ted.com/5-prescription-drugs-doctors-had-no-ide... ), and more information in general here ( https://www.bmj.com/open-data https://www.bmj.com/open-data ), and here ( https://www.livescience.com/8365-dark-side-medical-research-widespread-bias-omissions.html https://www.livescience.com/8365-dark-side-medical-research-... ) Pharmaceutical companies' only duty is to turn a profit to their shareholders. If they spend five or ten years developing a drug that they find has either no or negative use, then in the eyes of the shareholders, they have wasted that money. The duty of the company is to find a use for the drug regardless of whether it is useful or not, regardless of whether there is a more beneficial alternative. {0} - I copied this line, sue me :)
- lbeltrame 7y agoAs a contrast, and since you've mentioned Bad Pharma, I suggest reading also "Good Pharma" (https://www.amazon.com/Good-Pharma-Public-Health-Model-Institute/dp/1137388331 https://www.amazon.com/Good-Pharma-Public-Health-Model-Insti...). Disclaimer: the book mentions the institute where I'm currently employed, although the views and opinions I'm expressing are my own.
- Lol_80005 7y agoAs a contrast, and since you've mentioned Good Pharma, I suggest reading also "Bottle of Lies: The Inside Story of the Generic Drug Boom" ( https://www.amazon.com/dp/0062338781/ https://www.amazon.com/dp/0062338781/ ) This book discusses the supply line of generic drugs on US shelves today.
- elliekelly 7y agoThis is exactly why Gilead won’t allow the similar drug to be used in cats. They don’t want to know about negative side effects that might then hinder the drug’s approval for use in humans. If ever there has been a business decision to illustrate the whole “putting profits over people” this is it. And sunk costs, too.
- parhamn 7y ago> They don’t want to know about negative side effects that might then hinder the drug’s approval for use in humans. This argument actually threw me for a loop. Now I'm concerned about all the other drugs that the cats didn't use first. It must be the one major missing protocol from our vastly successful drug regulation system. /s
- elliekelly 7y agoIt’s not the lack of cat testing that rubs me the wrong way so much as the willful ignorance of potential risks/harm.
- deleted 7y ago[deleted]
- Alex3917 7y ago> I can assure you that Gilead has several magnitudes of more information about both of these molecules than the author has. Sounds like a good reason never to take either.
- refurb 7y agoHuh? Are you saying you'd only take drugs where random authors have as much information as the manufacturer?
- User23 7y agoAlso, phase three data costs hundreds of millions if not billions of dollars.
- philwelch 7y agoYeah, that’s almost certainly true. But it’s human nature to second-guess organizations that should know what they’re doing, and it makes for a fun mental diversion.
- hannob 7y ago> As someone who has been on the corporate side of this type of debate, I can assure you that Gilead has several magnitudes of more information about both of these molecules than the author has. Which is a neverending scandal that should outrage everyone.
- ohvigrinia 7y agoIt seems unlikely that a better but generic and out of patent drug, such as HCQ, would ever be main treatment, recommended by governments and pharma, given how much money is potentially capturable using remdesivir. As someone on the inside for these debates, perhaps you can tell me what if any justifications the decision makers in pharma make. I can imagine them saying, at least we'll eradicate HIV, so who cares.
- appleflaxen 7y agoI don't find this reasoning compelling. It is only an appeal to authority.